Copertina

Generative diffusion model enables quantification of calibration‐free arterial spin labeling perfusion magnetic resonance imaging data in an Alzheimer's disease cohort

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Qinyang Shou, Steven Cen, Nan‐kuei Chen, John M Ringman, Hosung Kim, Clifford R. Jack, Bret J. Borowski, Matthew L. Senjem, Arvin Arani, Danny J. J. Wang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Classifying mild cognitive impairment from normal cognition: fMRI complexity matches tau PET performance
di: Kay Jann, et al.
Pubblicazione: (2025)

Online46: Online cognitive assessments in elderly cohorts—The British 1946 birth cohort case study
di: Ziyuan Cai, et al.
Pubblicazione: (2025)

Navigating late‐stage dementia: A perspective from the Alzheimer's Association
di: Kristen Clifford, et al.
Pubblicazione: (2024)

Influence of cognitive, neuropsychiatric, and diagnostic factors on financial capacity: A longitudinal analysis of the ADNI cohort
di: Milap A. Nowrangi, et al.
Pubblicazione: (2025)

NODDI in gray matter is a sensitive marker of aging and early AD changes
di: Xi Yu, et al.
Pubblicazione: (2024)

Relationships among young adult general cognitive ability, midlife physical activity, and early late‐life cognitive functioning: A four‐decade longitudinal cohort study in men
di: Paula Iso‐Markku, et al.
Pubblicazione: (2025)

Treating Alzheimer's disease in a person living with HIV
di: David B. Clifford, et al.
Pubblicazione: (2026)

Clinical validation of the Lilly SP‐X P‐tau217 assay: Performance in underrepresented cohorts
di: Michael E. Hodsdon, et al.
Pubblicazione: (2025)

BDNF expression mediates verbal learning and memory in women in a cohort enriched with risk for Alzheimer's disease
di: Kyle J. Edmunds, et al.
Pubblicazione: (2025)

A novel method for objective quantification of apathy based on gaze and physiological reactivity to stimuli presented in a virtual reality environment
di: Ramit Ravona‐Springer, et al.
Pubblicazione: (2025)

Opportunities to encourage adoption of a biomarker‐enabled care pathway for Alzheimer's in primary care
di: Soo Borson, et al.
Pubblicazione: (2025)

Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort
di: Joyce R. Chong, et al.
Pubblicazione: (2024)

Age‐related macular degeneration severity and risk of Alzheimer's disease in older adults in a prospective, community‐based cohort study
di: Chloe A. Krakauer, et al.
Pubblicazione: (2026)

Association of arterial structure and function with incident cardiovascular diseases and cognitive decline
di: Caroline Robert, et al.
Pubblicazione: (2025)

Loneliness trajectories and dementia risk: Insights from the HUNT cohort study
di: Ragnhild Holmberg Aunsmo, et al.
Pubblicazione: (2025)

Clinical utility of CSF Aβ38 in Japanese research and clinical cohorts
di: Tamao Tsukie, et al.
Pubblicazione: (2025)

Feasibility of assessing cognitive impairment via distributed camera network and privacy‐preserving edge computing
di: Chaitra Hegde, et al.
Pubblicazione: (2025)

The association between multiple long‐term conditions and dementia: A UK cohort study
di: Hilary Shepherd, et al.
Pubblicazione: (2025)

Dementia ascertainment in India and development of nation‐specific cutoffs: A machine learning and diagnostic analysis
di: Danny Maupin, et al.
Pubblicazione: (2025)

Correction to “Retinal microvasculature and incident dementia over 10 years: The Three‐City‐Alienor cohort”
Pubblicazione: (2024)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
di: Xiang‐Sha Yin, et al.
Pubblicazione: (2025)

Evaluation of fully automated ApoE4 proteotyping for APOE ε4 genotype estimation in the FINDERI cohort
di: Hans‐Wolfgang Klafki, et al.
Pubblicazione: (2026)

Reliability of remote self‐administered Web‐based digital cognitive measures and comparison to in‐person neuropsychological tests: Stricker Learning Span, Symbols Test, and the Mayo Test Drive Screening Battery Composite
di: Morgan A. Hughes, et al.
Pubblicazione: (2026)

Proteomic profiling identifies serpin G1, ApoA‐II, and LBP as potential biomarkers of dementia in an Egyptian cohort
di: Shimaa A. Heikal, et al.
Pubblicazione: (2025)

Lecanemab treatment modulates brain volume and cerebrospinal fluid pathways in early Alzheimer's disease: Insights from longitudinal magnetic resonance imaging
di: Yuxin Li, et al.
Pubblicazione: (2026)

Association of apolipoprotein E genotype with cognitive performance: findings from the University of California, Davis Alzheimer's Disease Research Center longitudinal diversity cohort
di: Eva Min, et al.
Pubblicazione: (2026)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
di: Faheem Arshad, et al.
Pubblicazione: (2025)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
di: Yuhan Xie, et al.
Pubblicazione: (2025)

Long‐term Alzheimer's disease mortality prediction in adults aged ≥60 years: A prospective cohort study benchmarking survival machine learning algorithms
di: Xiaoping Huang, et al.
Pubblicazione: (2025)

Characterizing Japanese older adults without dementia by amyloid PET status: A comparative study of amyloid‐positive and amyloid‐negative groups from Japanese trial‐ready cohort study
di: Saki Nakashima, et al.
Pubblicazione: (2026)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
di: Ihab Hajjar, et al.
Pubblicazione: (2024)

The Rapid Naming Test: Neuroanatomical validity and clinical utility
di: Kelly J. Atkins, et al.
Pubblicazione: (2025)

Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies
di: Paul C. Donaghy, et al.
Pubblicazione: (2026)

White matter hyperintensities mediate a greater proportion of age‐related lower cognitive scores in non‐Hispanic White participants compared to non‐Hispanic Black and Hispanic participants: HABS‐HD
di: Cellas A. Hayes, et al.
Pubblicazione: (2026)

Dementia stigma in the United States: variation by target gender, degree of impairment, and respondent characteristics
di: Lucas J. Hamilton, et al.
Pubblicazione: (2026)

The relationship between anticholinergic burden and frailty in the year preceding a diagnosis of dementia with Lewy bodies
di: Kathryn A. Wyman‐Chick, et al.
Pubblicazione: (2024)

Family history, perceived risk, and perceived threat of Alzheimer's disease among Latino residents of northern Manhattan
di: Eleanor J. Murphy, et al.
Pubblicazione: (2026)

Midlife sensory and motor functions improve long‐term predictions of cognitive decline and incidence of cognitive impairment
di: Carla R. Schubert, et al.
Pubblicazione: (2024)

Midlife sensory and motor functions improve prediction of blood‐based measures of neurodegeneration and Alzheimer's disease in late middle‐age
di: Adam J. Paulsen, et al.
Pubblicazione: (2024)

Data‐driven neuropsychological phenotypes in the Baltimore Longitudinal Study of Aging
di: Caitlin M. Terao, et al.
Pubblicazione: (2025)